NCT01957176 2022-12-30A Rollover Study to Provide Continued Treatment With EltrombopagNovartisPhase 4 Completed22 enrolled 9 charts
NCT01890746 2019-09-11A Safety and Efficacy Study of Eltrombopag in Subjects With AMLNovartisPhase 2 Completed148 enrolled 42 charts